Induced pluripotent stem cell technology and stem cell therapy for diabetes.
作者： ROBERT J. DRUMMOND , TILO KUNATH , P. JOSEPH MEE , JAMES A. ROSS
DOI: 10.3892/ETM.2010.173
关键词:
摘要: Although diabetes can be managed clinically with the use of insulin injections, it remains an incurable and inconvenient disorder. In long-term, is associated a number clinical complications, such as cardiovascular disease, resulting in desire for development new methodologies to replace defective cells provide lasting normality without need drug treatment. Stem cells, including induced pluripotent stem offer possibility generating suitable transplantation due their capacity differentiate into all tissue lineages. However, many issues must addressed before this type treatment becomes reality, greater understanding underlying biology involved onset diabetes.
ed.ac.uk
sci-hub.se 参考文章(44)
Zhumur Ghosh, Kitchener D. Wilson, Yi Wu, Shijun Hu, Thomas Quertermous, Joseph C. Wu, Persistent Donor Cell Gene Expression among Human Induced Pluripotent Stem Cells Contributes to Differences with Human Embryonic Stem Cells PLoS ONE. ,vol. 5, pp. e8975- ,(2010) , 10.1371/JOURNAL.PONE.0008975
Mark H. Chin, Mike J. Mason, Wei Xie, Stefano Volinia, Mike Singer, Cory Peterson, Gayane Ambartsumyan, Otaren Aimiuwu, Laura Richter, Jin Zhang, Ivan Khvorostov, Vanessa Ott, Michael Grunstein, Neta Lavon, Nissim Benvenisty, Carlo M. Croce, Amander T. Clark, Tim Baxter, April D. Pyle, Mike A. Teitell, Matteo Pelegrini, Kathrin Plath, William E. Lowry, Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression Signatures Cell Stem Cell. ,vol. 5, pp. 111- 123 ,(2009) , 10.1016/J.STEM.2009.06.008
José Silva, Ian Chambers, Steven Pollard, Austin Smith, Nanog promotes transfer of pluripotency after cell fusion. Nature. ,vol. 441, pp. 997- 1001 ,(2006) , 10.1038/NATURE04914
I. Wilmut, A. E. Schnieke, J. McWhir, A. J. Kind, K. H. S. Campbell, Viable offspring derived from fetal and adult mammalian cells Nature. ,vol. 385, pp. 810- 813 ,(1997) , 10.1038/385810A0
In-Hyun Park, Rui Zhao, Jason A. West, Akiko Yabuuchi, Hongguang Huo, Tan A. Ince, Paul H. Lerou, M. William Lensch, George Q. Daley, Reprogramming of human somatic cells to pluripotency with defined factors Nature. ,vol. 451, pp. 141- 146 ,(2008) , 10.1038/NATURE06534
Hiroyuki Matsumura, Takashi Tada, Cell fusion-mediated nuclear reprogramming of somatic cells. Reproductive Biomedicine Online. ,vol. 16, pp. 51- 56 ,(2008) , 10.1016/S1472-6483(10)60556-1
Micha Drukker, Helena Katchman, Gil Katz, Smadar Even-Tov Friedman, Elias Shezen, Eran Hornstein, Ofer Mandelboim, Yair Reisner, Nissim Benvenisty, Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells Stem Cells. ,vol. 24, pp. 221- 229 ,(2006) , 10.1634/STEMCELLS.2005-0188
R. Briggs, T. J. King, Transplantation of Living Nuclei From Blastula Cells into Enucleated Frogs' Eggs Proceedings of the National Academy of Sciences of the United States of America. ,vol. 38, pp. 455- 463 ,(1952) , 10.1073/PNAS.38.5.455
Marius Wernig, Alexander Meissner, Ruth Foreman, Tobias Brambrink, Manching Ku, Konrad Hochedlinger, Bradley E. Bernstein, Rudolf Jaenisch, In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state Nature. ,vol. 448, pp. 318- 324 ,(2007) , 10.1038/NATURE05944
Jianjie Jiang, Melinda Au, Kuanghui Lu, Alana Eshpeter, Gregory Korbutt, Greg Fisk, Anish S. Majumdar, Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells. ,vol. 25, pp. 1940- 1953 ,(2007) , 10.1634/STEMCELLS.2006-0761